A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019

Loading...
Loading...

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. ACADIA Pharmaceuticals ACAD shares were up 62.9% after the company reported its HARMONY Phase 3 Trial met its primary endpoint. Needham maintained a Buy on the stock and raised the price target from $34 to $60.
  2. AT&T T shares are up 3.1% to $37.37. Elliot Management, which holds a $3.2 billion stake in the company, sent a letter detailing his recommendations on how to make the company worth $60 per share.
  3. SINTX Technologies SINT shares were up 16.7% to $1.61.
  4. Changeyou.com CYOU shares were up 49.8% after the company announced it received a preliminary non-binding proposal to acquire the company from Sohu for $10 per AD.
  5. Netflix UP shares were up 2.1% to $296. Bank of America noted the company’s download capability increased 30%.
  6. FuelCell Energy FCEL shares were up 34.9% to $0.55. The company reported better-than-expected Q3 EPS and sales results.
  7. Cesca Therapeutics KOOL shares were up 26.32% to $4.44 after the company entered into a global distribution agreement with ThermoGenesis to distribute its X-Series products.
  8. PaySign PAYS shares were down 18.7% to $9.78 after the company cut its preliminary 2019 sales guidance from $38 million-$40 million to $35-$37 million. The company cited delays in onboarding of the new plasma industry programs planned for Q1 and Q2.
  9. Roku ROKU shares were down 2% to $166.42. The company expanded its Roku TV licensing program in Europe.
  10. Cassava Sciences SAVA shares were down 6.7% to $1.30. The company reported positive phase 2a clinical results in alzheimer's patients, data supports initiation of a phase 2b study.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Trading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...